Publications by authors named "Qusai Alshare"

Claim this Profile
R
Retrospective evaluation of medication appropriateness in older adults with hepatic cirrhosis.
Qusai Y Al-Share, Aseel Y Tahrawi, Dyala M Khasawneh, Aya W Alshare, Shrouq A Alkhasawneh

Sci Prog· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of medication appropriateness index in cardiovascular outpatient clinic: A cross-sectional study.
Qusai Y Al-Share, Rawand A Khasawneh, Abeer M Rababa'h, Fadi N Asfar, Yara N Mohammad

Curr Pharm Teach Learn· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring angiogenic pathways in breast cancer: Clinicopathologic correlations and prognostic implications based on gene expression profiles from a large-scale genomic dataset.
Nehad M Ayoub, Salam Sardiah, Qusai Y Al-Share, Mohammad S Alkader

PLoS One· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Toxicity induced by orellanine from the mushroom Cortinarius orellanus in primary renal tubular proximal epithelial cells (RPTEC): Novel mechanisms of action.
Shreen D Nusair, Bayan Abandah, Qusai Y Al-Share, Luay Abu-Qatouseh, Mohammad I A Ahmad

Toxicon· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacogenomics of lipid-lowering agents: the impact on efficacy and safety.
Aymen Shatnawi, Zourayz Kamran, Qusai Al-Share

Per Med· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The influence of adverse drug effects on health-related quality of life in chronic obstructive pulmonary disease patients.
Shoroq M Altawalbeh, Basima A Almomani, Qais Alefan, Suleiman Mohammad Momany, Qusai Y Al-Share

Int J Pharm Pract· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Topical Ocular TRPV1 Antagonist SAF312 (Libvatrep) Demonstrates Safety, Low Systemic Exposure, and No Anesthetic Effect in Healthy Participants.
Kalliopi Stasi, Qusai Alshare, Monish Jain, Michael Wald, Yifang Li

Transl Vis Sci Technol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduced Hepatic Carcinoembryonic Antigen-Related Cell Adhesion Molecule 1 Level in Obesity.
Garrett Heinrich, Harrison T Muturi, Khadijeh Rezaei, Qusai Y Al-Share, Anthony M DeAngelis

Front Endocrinol (Lausanne)· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Loss of Hepatic CEACAM1: A Unifying Mechanism Linking Insulin Resistance to Obesity and Non-Alcoholic Fatty Liver Disease.
Garrett Heinrich, Hilda E Ghadieh, Simona S Ghanem, Harrison T Muturi, Khadijeh Rezaei

Front Endocrinol (Lausanne)· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role for hepatic CEACAM1 in regulating fatty acid metabolism along the adipocyte-hepatocyte axis.
Lucia Russo, Hilda E Ghadieh, Simona S Ghanem, Qusai Y Al-Share, Zachary N Smiley

J Lipid Res· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disposition and metabolism of [(14)C] Sacubitril/Valsartan (formerly LCZ696) an angiotensin receptor neprilysin inhibitor, in healthy subjects.
Jimmy Flarakos, Yancy Du, Timothy Bedman, Qusai Al-Share, Pierre Jordaan

Xenobiotica· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PPARα (Peroxisome Proliferator-activated Receptor α) Activation Reduces Hepatic CEACAM1 Protein Expression to Regulate Fatty Acid Oxidation during Fasting-refeeding Transition.
Sadeesh K Ramakrishnan, Saja S Khuder, Qusai Y Al-Share, Lucia Russo, Simon L Abdallah

J Biol Chem· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-fat diet amplifies renal renin angiotensin system expression, blood pressure elevation, and renal dysfunction caused by Ceacam1 null deletion.
Caixia Li, Silas A Culver, Syed Quadri, Kelly L Ledford, Qusai Y Al-Share

Am J Physiol Endocrinol Metab· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Forced Hepatic Overexpression of CEACAM1 Curtails Diet-Induced Insulin Resistance.
Qusai Y Al-Share, Anthony M DeAngelis, Sumona Ghosh Lester, Thomas A Bowman, Sadeesh K Ramakrishnan

Diabetes· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatic CEACAM1 Over-Expression Protects Against Diet-Induced Fibrosis and Inflammation in White Adipose Tissue.
Sumona G Lester, Lucia Russo, Simona S Ghanem, Saja S Khuder, Anthony M DeAngelis

Front Endocrinol (Lausanne)· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of nonalcoholic steatohepatitis in insulin-resistant liver-specific S503A carcinoembryonic antigen-related cell adhesion molecule 1 mutant mice.
Sang Jun Lee, Garrett Heinrich, Larisa Fedorova, Qusai Y Al-Share, Kelly J Ledford

Gastroenterology· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aerobic interval training versus continuous moderate exercise as a treatment for the metabolic syndrome: a pilot study.
Arnt Erik Tjønna, Sang Jun Lee, Øivind Rognmo, Tomas O Stølen, Anja Bye

Circulation· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Insulin acutely decreases hepatic fatty acid synthase activity.
Sonia M Najjar, Yan Yang, Mats A Fernström, Sang-Jun Lee, Anthony M Deangelis

Cell Metab· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiovascular risk factors emerge after artificial selection for low aerobic capacity.
Ulrik Wisløff, Sonia M Najjar, Oyvind Ellingsen, Per Magnus Haram, Steven Swoap

Science· January 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interaction between altered insulin and lipid metabolism in CEACAM1-inactive transgenic mice.
Tong Dai, George A Abou-Rjaily, Qusai Y Al-Share', Yan Yang, Mats A Fernström

J Biol Chem· October 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CEACAM1 modulates epidermal growth factor receptor--mediated cell proliferation.
George A Abou-Rjaily, Sang Jun Lee, Denisa May, Qusai Y Al-Share, Anthony M Deangelis

J Clin Invest· October 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis